Melanoma has long been one of oncology’s most instructive adversaries. Roughly half of all melanomas are driven by mutations ...
Mayo Clinic researchers have shown that approved thyroid cancer drugs can restore a key antigen on aggressive tumour cells, making them visible once more to CAR T cells and improving treatment ...